AYTUAYTU BIOPHARMA, INC

Nasdaq aytubio.com


$ 2.74 $ -0.09 (-3.25 %)    

Wednesday, 24-Apr-2024 11:35:02 EDT
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 2.81
$ 2.69
$ 0.00 x 0
$ 0.00 x 0
$ 2.69 - $ 2.74
$ 1.38 - $ 3.50
4,018
na
9.39M
$ -0.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-14-2024 12-31-2023 10-Q
2 11-14-2023 09-30-2023 10-Q
3 10-12-2023 06-30-2023 10-K
4 05-11-2023 03-31-2023 10-Q
5 02-21-2023 12-31-2022 10-Q
6 11-14-2022 09-30-2022 10-Q
7 09-27-2022 06-30-2022 10-K
8 05-16-2022 03-31-2022 10-Q
9 02-14-2022 12-31-2021 10-Q
10 11-15-2021 09-30-2021 10-Q
11 09-28-2021 06-30-2021 10-K
12 05-17-2021 03-31-2021 10-Q
13 02-11-2021 12-31-2020 10-Q
14 11-12-2020 09-30-2020 10-Q
15 10-06-2020 06-30-2020 10-K
16 05-15-2020 03-31-2020 10-Q
17 02-14-2020 12-31-2019 10-Q
18 11-14-2019 09-30-2019 10-Q
19 09-26-2019 06-30-2019 10-K
20 05-14-2019 03-31-2019 10-Q
21 02-07-2019 12-31-2018 10-Q
22 11-07-2018 09-30-2018 10-Q
23 09-06-2018 06-30-2018 10-K
24 05-14-2018 03-31-2018 10-Q
25 02-08-2018 12-31-2017 10-Q
26 11-09-2017 09-30-2017 10-Q
27 08-31-2017 06-30-2017 10-K
28 05-11-2017 03-31-2017 10-Q
29 02-09-2017 12-31-2016 10-Q
30 11-07-2016 09-30-2016 10-Q
31 09-01-2016 06-30-2016 10-K
32 05-11-2016 03-31-2016 10-Q
33 02-11-2016 12-31-2015 10-Q
34 11-06-2015 09-30-2015 10-Q
35 09-28-2015 06-30-2015 10-K
36 05-19-2015 03-31-2015 10-Q
37 04-15-2015 02-28-2015 10-Q
38 01-12-2015 11-30-2014 10-Q
39 11-26-2014 08-31-2014 10-K
40 07-10-2014 05-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aytu-biopharma-q2-2024-gaap-eps-004-beats-025-estimate-sales-2293m-beat-2175m-estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.25...

 earnings-scheduled-for-february-14-2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

 earnings-preview-aytu-biopharma
Earnings Preview: Aytu BioPharma
02/13/2024 19:02:10

 why-shapeways-holdings-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

 aytu-biopharma-q1-eps-148-down-from-120-yoy-sales-2210m-miss-2773m-estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(1.48) per share. This is a 23.33 percent decrease over losses of $(...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 biggest-short-squeeze-stocks-of-the-week-biotech-stocks-dominate-a-bitcoin-related-stock-moves-up-leaderboard

Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the n...

 aytu-biopharma-announces-approval-of-the-cotempla-xr-odt-manufacturing-site-transfer-prior-approval-supplement

U.S. Food & Drug Administration Approval of the Prior Approval Supplement (PAS) Enables Transfer of Cotempla Production to ...

 why-carmax-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its p...

 reported-september-27-aytu-biopharma-q4-eps-059-beats-095-estimate-sales-3073m-beat-2769m-estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.95...

 earnings-scheduled-for-september-27-2023

Companies Reporting Before The Bell • Paychex (NASDAQ:PAYX) is projected to report quarterly earnings at $1.12 per share on re...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION